Assessing atopic disease in children two to six years old: reliability of a revised questionnaire.
BACKGROUND
Primary intervention - reducing second hand smoking (SHS), indoor dampness, and increased intake of omega-3-fatty acids - for allergic diseases such as asthma, rhinoconjunctivitis, and eczema/dermatitis in children was started in Trondheim in 2002. To our knowledge, no validated or reliable questionnaires for the study age groups were available.


OBJECTIVE
To test the reliability of a revised questionnaire for studying atopic disease in children two to six years old in Trondheim.


METHODS
Seventy-seven families were invited to fill in a questionnaire adapted from the ISAAC protocol which was made appropriate for the age group studied. Completed questionnaires and information from medical records were compared, and the agreement was analysed by Kappa statistics and proportional agreement.


RESULTS
Agreement was excellent for questions reporting current information such as doctor-diagnosed asthma (kappa=0.88), whether or not the child had had an allergy test (kappa=0.82), and use of antibiotics (kappa=0.81). The agreement was good for questions concerning doctor or hospital treatment for asthma (kappa=0.59), medication for asthma (kappa=0.58), symptoms of eczema (kappa=0.56), medication for allergic disease (kappa=0.45), and past infections (kappa=0.53).


CONCLUSIONS
Questions on asthma diagnosis, allergy testing, and use of antibiotics were reliable. Questions on medical treatment for eczema, allergic rhinoconjunctivitis and infections were less reliable, representing a potential source of information bias and possible misclassification.
Øien
Torbjørn
T
Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. torbjorn.oien@ntnu.no
Storrø
Ola
O
Johnsen
Roar
R
D001249:Asthma / Q000175:diagnosis*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003231:Conjunctivitis / Q000175:diagnosis*; D004485:Eczema / Q000175:diagnosis*; D005240:Feasibility Studies; D017144:Focus Groups; D006801:Humans; D010865:Pilot Projects; D015203:Reproducibility of Results; D012220:Rhinitis / Q000175:diagnosis*; D011795:Surveys and Questionnaires